Loratadin of the tab. of 10 mg No. 10, 20

General characteristics. Structure:

Active ingredient: лоратадин: 1 tablet contains a loratadin the 10th mg:vspomogatelny substances.

Pharmacological properties:

Antiallergic means, blocker of N - receptors of long action. Does not possess sedation. Shows antiallergic, antieskudativny and antipruritic activity. Reduces permeability, capillaries, eliminates a spasm of unstriated muscles, edematization of fabrics warns.
The therapeutic effect is reached in 1-3 hours, the maximum effect in 8-12 hours, action duration - 24 hours.

Indications to use:

Apply at adults and children is more senior than 2 years at allergic seasonal and year-round rhinitis, conjunctivitis, hay fever, a small tortoiseshell, allergic dermatitis, a Quincke's edema, allergic reactions to stings of insects, in complex treatment of a pruritic dermatosis (contact dermatitis, chronic dermatitis, chronic eczema).

Route of administration and doses:

To adults and children 12 years of-10 mg (1 tablet) of 1 times a day are aged more senior; to children aged from 2 up to 12 years with body weight less than 30 kg - 5 mg (1/2 tablets), with body weight more than 30 kg-10 mg (1 tablet) of 1 times a day. Duration of a course of treatment is up to 7 days.

Features of use:

Though Loratadin is also not sedative antihistamine, nevertheless at some patients dozozavisimy sedative affect can be observed. At use of drug in therapeutic doses with alcohol development of dozozavisimy sedation is possible. Use of drug does not influence ability to be engaged in potentially dangerous types of activity requiring special attention and speed of psychomotor reactions.

Side effects:

Drug is usually well transferred, are in rare instances possible - nausea, vomiting, a xerostomia.

Interaction with other medicines:

If you accept any other medicines, surely report about it to the doctor and if you are treated independently, consult with the doctor about a possibility of use of drug. Simultaneous use of drug with Cimetidinum, erythromycin, ketokonazoly which can break metabolism of a loratadin probably at the expense of inhibition of isoenzyme III A4 of P450 cytochrome that leads to increase in its concentration in blood serum is not recommended.
At co-administration with other blockers of N - receptors, barbiturates, benzodiazepines, agonists of opioid receptors, neuroleptics, tricyclic antidepressants, ethanol, anxiolytics. sedative and hypnagogues, development of dozozavisimy sedation is possible.

Contraindications:

Loratadin is contraindicated at hypersensitivity to active ingredients, children aged up to 2 years, and also during pregnancy and feeding by a breast.

Storage conditions:

It is forbidden to use drug after the period of validity specified on packaging.
To store in the dry, protected from light place, at the room temperature. To store in the place, unavailable to children.
Drug period of validity - 2 years.

Issue conditions:

Without recipe

Packaging:

On 20 (10x2) tablets in a blister strip packaging.